Search
Patexia Research
Case number 3:20-cv-02738

BAUSCH HEALTH US, LLC et al v. AUROBINDO PHARMA USA INC. et al > Documents

Date Field Doc. No.Description (Pages)
May 14, 2020 N/A Terminated Case (0)
Docket Text: ***Civil Case Terminated. (jmh)
May 14, 2020 11 Order (3)
Docket Text: ORDER CONSOLIDATING CASES FOR ALL PURPOSES. Civil Action Nos. 20-2735, 20-2738, 20-2742, 20-2747, 20-2744 and 20-2748 are consolidated with Civil Action No. 18-13635 for all purposes, including discovery, case management, and trial, subject to further order of the Court. Signed by Judge Brian R. Martinotti on 05/14/2020. (jmh)
Apr 17, 2020 9 Answer to Complaint (31)
Apr 17, 2020 9 Exhibit A - Civil Cover Sheet (2)
Apr 17, 2020 10 Corporate Disclosure Statement (aty) (2)
Docket Text: Corporate Disclosure Statement by AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA INC. identifying Aurobindo Pharma LTD as Corporate Parent.. (YOUNGELSON, MARC)
Apr 17, 2020 9 Main Document (31)
Docket Text:Aurobindo's ANSWER to Complaint , COUNTERCLAIM against All Plaintiffs by AUROBINDO PHARMA USA INC., AUROBINDO PHARMA LTD.. (Attachments: # (1) Exhibit A - Civil Cover Sheet)(YOUNGELSON, MARC)
Apr 13, 2020 8 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE Returned Executed by BAUSCH HEALTH US, LLC, BAUSCH HEALTH IRELAND LIMITED, KAKEN PHARMACEUTICAL CO., LTD., BAUSCH HEALTH AMERICAS, INC.. AUROBINDO PHARMA LTD. waiver sent on 3/19/2020, answer due 5/18/2020; AUROBINDO PHARMA USA INC. waiver sent on 3/19/2020, answer due 5/18/2020. (DENI, WILLIAM)
Mar 19, 2020 7 Notice of Appearance (2)
Docket Text: NOTICE of Appearance by MARC D. YOUNGELSON on behalf of AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA INC. (YOUNGELSON, MARC)
Mar 13, 2020 6 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by J. BRUGH LOWER on behalf of BAUSCH HEALTH AMERICAS, INC., BAUSCH HEALTH IRELAND LIMITED, BAUSCH HEALTH US, LLC, KAKEN PHARMACEUTICAL CO., LTD. (LOWER, J.)
Mar 12, 2020 N/A Add and Terminate Judges (0)
Docket Text: Judge Brian R. Martinotti and Magistrate Judge Lois H. Goodman added. (mg)
Mar 12, 2020 1 Complaint (15)
Mar 12, 2020 1 Exhibit A (12)
Mar 12, 2020 1 Exhibit B (16)
Mar 12, 2020 1 Exhibit C (36)
Mar 12, 2020 1 Civil Cover Sheet (1)
Mar 12, 2020 1 L. Civ. R. 11.2 Certification (2)
Mar 12, 2020 2 Corporate Disclosure Statement (aty) (1)
Docket Text: Corporate Disclosure Statement by BAUSCH HEALTH AMERICAS, INC., BAUSCH HEALTH IRELAND LIMITED, BAUSCH HEALTH US, LLC. (DENI, WILLIAM)
Mar 12, 2020 3 Corporate Disclosure Statement (aty) (2)
Docket Text: Corporate Disclosure Statement by KAKEN PHARMACEUTICAL CO., LTD.. (DENI, WILLIAM)
Mar 12, 2020 4 AO120 Patent/Trademark Form (1)
Docket Text: AO120 Patent Form filed. (mg)
Mar 12, 2020 5 Summons Issued (2)
Docket Text: SUMMONS ISSUED as to AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (mg)
Mar 12, 2020 1 Main Document (15)
Docket Text: COMPLAINT against AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA INC., filed by BAUSCH HEALTH US, LLC, BAUSCH HEALTH IRELAND LIMITED, KAKEN PHARMACEUTICAL CO., LTD., BAUSCH HEALTH AMERICAS, INC.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Civil Cover Sheet, # (5) L. Civ. R. 11.2 Certification)(DENI, WILLIAM)
Mar 12, 2020 1 Complaint* (1)
Menu